StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.01−0.01 (-0.50%)

Close on Nov 17, 2026Market cap $14.81MP/E –Yield –

GeoVax Labs market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

GeoVax Labs's market cap was $15.92M on Nov 11, 2026, against $305.30M a year earlier. Over the last 5 years it ranged from $2.46M to $232.13B, with a median of $9.77B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$15.92M-87.5%
2025Dec 31, 2025$126.99M-99.0%
2024Dec 31, 2024$12.76B-85.3%
2023Dec 29, 2023$86.72B-41.9%
2022Dec 30, 2022$149.35B-28.2%
2021Dec 31, 2021$207.88B+92.0%
2020Dec 31, 2020$108.27B+147697.3%
2019Sep 30, 2019$73.25M+14.1%
2018Dec 31, 2018$64.23M+67.7%
2017Dec 29, 2017$38.29M-27.9%
2016Dec 30, 2016$53.11M+31.9%
2015Dec 31, 2015$40.26M-99.4%
2014Dec 31, 2014$6.71B+2973.5%
2013Dec 31, 2013$218.40M-0.4%
2012Dec 31, 2012$219.18M-15.2%
2011Dec 30, 2011$258.54M-18.5%
2010Dec 31, 2010$317.20M–

More GeoVax Labs figures

See a number that looks wrong?